{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:58:42Z","timestamp":1785189522253,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T00:00:00Z","timestamp":1489795200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00415-017-8463-6","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T10:20:47Z","timestamp":1489832447000},"page":"921-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-2900","authenticated-orcid":false,"given":"Vincenzo","family":"Belcastro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Rosa","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Bellocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Gorgone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"key":"8463_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430","journal-title":"Lancet Neurol"},{"key":"8463_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1056\/NEJM200101113440207","volume":"344","author":"LM Angelis De","year":"2001","unstructured":"De Angelis LM (2001) Brain Tumors. N Engl J Med 344:114\u2013123","journal-title":"N Engl J Med"},{"key":"8463_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1468-1331.2010.03151.x","volume":"17","author":"R Soffietti","year":"2010","unstructured":"Soffietti R, Baumert BG, Bello L et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124\u20131133","journal-title":"Eur J Neurol"},{"key":"8463_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/neuonc\/nos199","volume":"14","author":"R Rud\u00e0","year":"2012","unstructured":"Rud\u00e0 R, Bello L, Duffau H et al (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14:55\u201364","journal-title":"Neuro Oncol"},{"key":"8463_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/157015912800604470","volume":"10","author":"M Maschio","year":"2012","unstructured":"Maschio M (2012) Brain tumor-related epilepsy. Curr Neuropharmacol 10:124\u2013133","journal-title":"Curr Neuropharmacol"},{"key":"8463_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yebeh.2015.03.016","volume":"48","author":"Z Rahman","year":"2015","unstructured":"Rahman Z, Wong CH, Dexter M et al (2015) Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav 48:88\u201395","journal-title":"Epilepsy Behav"},{"key":"8463_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/epi.12452","volume":"54","author":"E Perucca","year":"2013","unstructured":"Perucca E (2013) Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia 54:97\u2013104","journal-title":"Epilepsia"},{"key":"8463_CR8","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.2165\/11594640-000000000-00000","volume":"71","author":"C Fattore","year":"2011","unstructured":"Fattore C, Perucca E (2011) Novel medications for epilepsy. Drugs 71:2151\u20132178","journal-title":"Drugs"},{"key":"8463_CR9","doi-asserted-by":"publisher","unstructured":"Pisani LR, Belcastro V, Oteri G, Pisani F (2013) Principles and current issues of antiepileptic drug therapy. In: Atta-ur-Rahman (ed) Frontiers in Clinical Drug Research\u2014CNS and neurological disorders, vol 1. Bentham Science Publishers, USA, pp 149\u2013229","DOI":"10.2174\/9781608057580113010008"},{"key":"8463_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1215\/15228517-2007-057","volume":"10","author":"SD Arnold","year":"2008","unstructured":"Arnold SD, Forman LM, Brigidi BD et al (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10:171\u2013181","journal-title":"Neuro Oncol"},{"key":"8463_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/NDT.S65874","volume":"11","author":"FW Boele","year":"2015","unstructured":"Boele FW, Rooney AG, Grant R et al (2015) Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat 11:1413\u20131420","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8463_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1503\/cmaj.111622","volume":"184","author":"D Cavers","year":"2012","unstructured":"Cavers D, Hacking B, Erridge SE et al (2012) Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. Can Med Assoc J 184:373\u2013382","journal-title":"Can Med Assoc J"},{"key":"8463_CR13","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/brain\/awu183","volume":"137","author":"F Campanella","year":"2014","unstructured":"Campanella F, Shallice T, Ius T et al (2014) Impact of brain tumour location on emotion and personality: a voxel-based lesion\u2013symptom mapping study on mentalization processes. Brain 137:2532\u20132545","journal-title":"Brain"},{"key":"8463_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2005.09.024","volume":"68","author":"FG Gilliam","year":"2006","unstructured":"Gilliam FG, Santos JM (2006) Adverse psychiatric effects of antiepileptic drugs. Epilepsy Res 68:67\u201369","journal-title":"Epilepsy Res"},{"key":"8463_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"R Fisher","year":"2014","unstructured":"Fisher R, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475\u2013482","journal-title":"Epilepsia"},{"key":"8463_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/B978-0-12-374006-9.00016-3","volume-title":"Psychiatric controversies in epilepsy","author":"AM Kanner","year":"2008","unstructured":"Kanner AM (2008) Should a psychiatric evaluation be included in every presurgical work-up? In: Kanner AM, Schachter S (eds) Psychiatric controversies in epilepsy. Elsevier Inc, San Diego, pp 239\u2013254"},{"key":"8463_CR17","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1684\/j.1950-6945.2003.tb00026.x","volume":"5","author":"E Perucca","year":"2003","unstructured":"Perucca E, Johannessen SI (2003) The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disord 5:S17\u2013S26","journal-title":"Epileptic Disord"},{"key":"8463_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.seizure.2015.07.004","volume":"31","author":"A Verrotti","year":"2015","unstructured":"Verrotti A, Prezioso G, Di Sabatino F et al (2015) The adverse event profile of levetiracetam: a meta-analysis on children and adults. Seizure 31:49\u201355","journal-title":"Seizure"},{"key":"8463_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jocn.2015.01.025","volume":"22","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Peizhi Z, Maling G et al (2015) The efficacy of levetiracetam for patients with supratentorial brain tumors. J Clin Neurosci 22:1227\u20131231","journal-title":"J Clin Neurosci"},{"key":"8463_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","volume":"86","author":"T Iuchi","year":"2015","unstructured":"Iuchi T, Kuwabara K, Matsumoto M et al (2015) Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry 86:1158\u20131162","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8463_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-016-2146-5","volume":"129","author":"ZG Nasr","year":"2016","unstructured":"Nasr ZG, Paravattil B, Wilby KJ (2016) Levetiracetam for seizure prevention in brain tumor patients: a systematic review. J Neurooncol 129:1\u201313","journal-title":"J Neurooncol"},{"key":"8463_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","volume":"61","author":"M Mula","year":"2003","unstructured":"Mula M, Trimble MR, Yuen A et al (2003) Psychiatric adverse events during levetiracetam therapy. Neurology 61:704\u2013706","journal-title":"Neurology"},{"key":"8463_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/brain\/awr310","volume":"135","author":"M Groot De","year":"2012","unstructured":"De Groot M, Reijneveld JC, Aronica E et al (2012) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135:1002\u20131016","journal-title":"Brain"},{"key":"8463_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","volume":"104","author":"M Maschio","year":"2011","unstructured":"Maschio M, Dinapoli L, Sperati F et al (2011) Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neurooncol 104:205\u2013214","journal-title":"J Neurooncol"},{"key":"8463_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yebeh.2015.03.018","volume":"45","author":"M Mula","year":"2015","unstructured":"Mula M, Agrawal N, Mustafa Z et al (2015) Self-reported aggressiveness during treatment with levetiracetam correlates with depression. Epilepsy Behav 45:64\u201367","journal-title":"Epilepsy Behav"},{"key":"8463_CR26","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1528-1167.2007.01262.x","volume":"48","author":"M Mula","year":"2007","unstructured":"Mula M, Trimble MR, Sander JW (2007) Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia 48:2322\u20132326","journal-title":"Epilepsia"},{"key":"8463_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/epi.13118","volume":"56","author":"V Barbieri","year":"2015","unstructured":"Barbieri V, Cardinale F, Gozzo F et al (2015) Risk factors for postoperative depression: a retrospective analysis of 248 subjects operated on for drug-resistant epilepsy. Epilepsia 56:149\u2013155","journal-title":"Epilepsia"},{"key":"8463_CR28","first-page":"405","volume":"27","author":"M Semkovska","year":"2001","unstructured":"Semkovska M, B\u00e9dard MA, Stip E (2001) Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives. Encephale 27:405\u2013415","journal-title":"Encephale"},{"key":"8463_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.nicl.2013.05.002","volume":"2","author":"YH Chen","year":"2013","unstructured":"Chen YH, Edgar JC, Huang M et al (2013) Frontal and superior temporal auditory processing abnormalities in schizophrenia. Neuroimage Clin 2:695\u2013702","journal-title":"Neuroimage Clin"},{"key":"8463_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/schbul\/sbw036","volume":"42","author":"AB Poppe","year":"2016","unstructured":"Poppe AB, Barch DM, Carter CS et al (2016) Reduced Fronto-parietal activity in schizophrenia is linked to a specific deficit in goal maintenance: a multisite functional imaging study. Schizophr Bull 42:1149\u20131157","journal-title":"Schizophr Bull"},{"key":"8463_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1528-1157.1999.tb00886.x","volume":"40","author":"ES Krishnamoorthy","year":"1999","unstructured":"Krishnamoorthy ES, Trimble MR (1999) Forced normalization: clinical and therapeutic relevance. Epilepsia 40:57\u201364","journal-title":"Epilepsia"},{"key":"8463_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/JCP.0b013e318253a186","volume":"32","author":"CM Eddy","year":"2012","unstructured":"Eddy CM, Rickards HE, Cavanna AE (2012) Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol 32:362\u2013375","journal-title":"J Clin Psychopharmacol"},{"key":"8463_CR33","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/brain\/aww196","volume":"139","author":"Z Chen","year":"2016","unstructured":"Chen Z, Lusicic A, O\u2019Brien TJ, Velakoulis D, Adams SJ, Kwan P (2016) Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain 139:2668\u20132678","journal-title":"Brain"},{"key":"8463_CR34","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886\u20131893","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8463-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T03:13:16Z","timestamp":1719112396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8463-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,18]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["8463"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8463-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,18]]}}}